Reducing Clinical Inertia in Kidney Transplant Patients with Hypertension
Author Information
Author(s): Kiberd James, Panek Romauld, Kiberd Bryce
Primary Institution: Dalhousie University
Hypothesis
Does the introduction of the BpTRU automated device lead to more therapeutic changes in hypertensive kidney transplant recipients?
Conclusion
Using automated blood pressure measurement devices can help reduce clinical inertia in treating hypertension among kidney transplant patients.
Supporting Evidence
- Before using the BpTRU device, only 36% of patients had a change in therapy.
- After introducing the BpTRU, 56% of patients had a change in therapy.
- Therapeutic changes were associated with higher blood pressures and the use of the BpTRU device.
Takeaway
This study found that using a special machine to measure blood pressure helped doctors make more changes to treat high blood pressure in kidney transplant patients.
Methodology
A retrospective analysis comparing changes in therapy before and after the introduction of the BpTRU device.
Potential Biases
Potential biases due to the retrospective nature and lack of randomization.
Limitations
The study was not randomized or blinded, and it used historic controls rather than concurrent ones.
Participant Demographics
Adults (>18 years) who were kidney alone or combined kidney-pancreas transplant recipients.
Statistical Information
P-Value
0.002
Confidence Interval
95% CI 1.04–1.12 for systolic BP, 95% CI 1.72–3.83 for BpTRU use
Statistical Significance
p=0.002
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website